TORONTO, ONTARIO – TheNewswire - July 28, 2025 - A-Labs Capital II Corp. (the “Company”) (TSXV: ALAB-P.V) announces that it has made application to the TSX Venture Exchange (the “Exchange”) seeking the resumption of trading of the Company’s common shares on the Exchange.   The common shares were halted by the Exchange on October 2, 2020 in connection with the entering into of a non-binding letter of intent with RDARS Inc. in respect of a proposed qualifying transaction.  The transaction with RDARS Inc. was terminated on March 22, 2021 and the Company’s common shares have remained halted. No monies were advanced by the Company, and there are no residual liabilities or guarantees to or by the Company, related to any of the terminated proposed qualifying transactions.

 

In connection with the application for resumption of trading, the Company acknowledges that it is deficient in meeting the Exchange requirements regarding the holding of annual general meetings of shareholders (an “AGM”) as it has not held an AGM since March 11, 2021. Initially the Company delayed holding an AGM as it had entered into successive letters of intent for qualifying transactions and expected that an AGM would be required in connection with the completion of a qualifying transaction.   Following the termination of the last proposed qualifying transaction on March 22, 2023, the Company’s financial position inhibited its ability to hold an AGM.

The Company has identified an investor group that has indicated a willingness to provide financing to the Company.  The common shares of the Company must resume trading in order for the Company to be able to pursue this financing opportunity.  

The Company intents to call an AGM to be held as soon as possible and, in any event, on or prior to September 16, 2025.   The ability of the Company to call and hold an AGM is subject to the Company being able to pay for the associated costs and the ability to do so is dependent on the completion of the proposed financing, which in turn is dependent on the common shares of the Company being resume for trading on the Exchange.

If the application for resumption of trading is accepted by the Exchange, the Company will be placed on a 90-day Exchange Notice due to the Company’s failure to hold an AGM within the required 15 month period, as required by Section 4.1 of Exchange Policy 3.2...    

 

For further information, please contact:

 

Doron Cohen
Chief Executive Officer
Telephone: (972) 54-522-4017
E-mail: Doron@alabs.co

  

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.